Navigation Links
Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
Date:10/29/2008

Data also found SYMBICORT opened airways in less than 15 minutes

WILMINGTON, Del., Oct. 29 /PRNewswire-FirstCall/ -- Data presented today from two pivotal efficacy and safety trials, SHINE and SUN, demonstrated that SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol significantly improved lung function and was well-tolerated in patients with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD) relative to budesonide and formotorol administered alone, and placebo.(1,2,3,4) Both trials showed safety profiles consistent with the established profiles in asthma for each product.(2,4) In addition, an analysis of these trials showed that patients receiving SYMBICORT achieved a bronchodilatory effect, or opening of the airways, similar to formoterol DPI, and a more rapid effect than that achieved by either budesonide pMDI or placebo.(5) Results were presented today at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians, held in Philadelphia, October 25-30, 2008.

In April 2008, AstraZeneca submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for SYMBICORT for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema. SYMBICORT is a combination therapy currently indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older.(6) SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of asthma.(6)

"Results of the SHINE and SUN trials demonstrated that SYMBICORT improved lung function and was well-tolerated by study patients with COPD,(1,2,3,4) and if approved by the FDA, it could offer a new treatment option for the millions of Americans suffering from this debilitating disease," said lead investigator Donald Tashkin, M.D., of the University of California, Los Angeles (U
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
2. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
3. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
4. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
5. Recruitment Completed in Ofatumumab NHL Pivotal Study
6. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
7. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
8. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
9. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
10. Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
11. First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
(Date:7/10/2014)... Israel , July 10, 2014   ... Diabetes Management Solution, today announced the appointment of ... independent member of its Board of Directors. ... legal and business experience to LabStyle as an ... and legal and corporate governance expert. He currently ...
(Date:1/15/2014)... 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced ... 2013, compared to sales of $2,202,000 for the prior year ... quarter has also shown growth over the preceding quarter,s sales, ... this fiscal year. Markets that experienced sales increases over the ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... Baxa Corporation, a leading,provider of systems for safe ... addition of two new international product,distributors. These agreements ... Pentafarma & Co. in The Dominican Republic -- ... expand product promotion in South,America and the Caribbean. ...
... Design ... and Test AIDS Vaccines, NEW YORK, Sept. ... from Executive Director,Mitchell Warren about the announcement that vaccinations have been,discontinued ... candidate developed by the Merck Research Laboratories: "Today,s announcement about ...
Cached Medicine Technology:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result 2AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result 3
(Date:7/10/2014)... "Mississippi baby" an infant seemingly cured of HIV that ... of HIV infection in The New England Journal of ... more than two years of not taking antiretroviral therapy without ... researchers involved in the case. , "Certainly, this ... the medical staff involved in the child,s care, and the ...
(Date:7/10/2014)... Mich. For those students looking to bump up ... not be spending more time in a library or ... State University research shows that students who were members ... campus during their freshman and sophomore years had higher ... also indicated that students with memberships stayed in school ...
(Date:7/10/2014)... Minn. The benefits of medical imaging far outweigh ... The Right Way, with The Right Radiation Dose. However, ... and Mayo Clinic is leading a collaborative effort to ... commentary, published online in the Journal of Patient ... the Joint Commission, the Intersociety Accreditation Commission, and the ...
(Date:7/10/2014)... shown that more severe illness and even death are ... infection after developing influenza. Now, however, a team of ... if you reverse the order of infection, the bacteria ... protect against a bad case of the flu. ... which is described as a bacterial virulence factor, might ...
(Date:7/10/2014)... brain operates much the same whether active or at ... understanding of schizophrenia, bipolar disorder and other serious mental ... , In newly published research in the journal ... Center for Molecular and Behavioral Neuroscience, determined that the ... basically the same as that of a person performing ...
Breaking Medicine News(10 mins):Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Want a higher GPA in college? Join a gym 2Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:Bacterial colonization prior to catching the flu may protect against severe illness 2Health News:Working to loosen the grip of severe mental illness 2
... Carlton Turner as Chairman, Robert Schnitzius as Acting President & CEO ... 11 DelSite, Inc. (OTC Bulletin Board: DSII.OB), a drug delivery ... of directors for the Company, has resigned his position as chairman, ... board until his term ends in May 2009. , ...
... BUFFALO, N.Y. -- Using the bells and whistles of ... School of Education project aims to improve the driving ... risk pool, and at the same time bring child ... The population identified as risky drivers: teenagers with ADHD ...
... DreamPak Nutritional Supplements,has developed a new revolutionary appetite and ... suppress their desire to eat,and reduce their food intake, ... eat less but still feel satisfied. Additionally, Trimma(TM),comes in ... to,satisfy their chocolate and sweet cravings. , ...
... Well at 100! , , WEST ... celebrated her 100th birthday. This year, to her great joy, she was ... a partial corneal transplant that has a much shorter recovery time than ... New Jersey. , , Katherine, who ...
... the adult heart is unable to regenerate. Now, researchers ... Medicine (MDC) Berlin-Buch and the Charit Universittsmedizin Berlin ... no longer holds true. Dr. Laura Zelarayn and Assistant ... that the body`s own heart muscle stem cells do ...
... Holidays are always fraught with,tension. This year, with the country ... maintain holiday cheer. While they won,t change the,economy, a ... they need this holiday season. , ... , Six Seconds is ...
Cached Medicine News:Health News:DelSite Chairman George DeMott Resigns 2Health News:DelSite Chairman George DeMott Resigns 3Health News:UB driver simulation study targets high-risk teenage drivers 2Health News:UB driver simulation study targets high-risk teenage drivers 3Health News:Trimma(TM) Now Available in the United States for People Looking for a Delicious Way to Control Their Calories 2Health News:Centenarian's Vision Restored With New Sutureless Corneal Transplant Technology 2Health News:Heart regenerates after infarction -- first trials with mice 2Health News:Holiday Cheer or Holiday Fear? Free Resource for a Happier Holiday 2
Inquire...
Inquire...
... Before TOPscan Dispensers used to only have two ... process the completed job at a wholesale lab, ... The alternative was to finish the order in ... additional offices required another edger, lens inventory, more ...
Inquire...
Medicine Products: